Karthik S Udupa
Overview
Explore the profile of Karthik S Udupa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
S P S, Patil S, Kumar R, Prasad K, Vijay D, Malhotra M, et al.
Cureus
. 2025 Jan;
16(12):e75622.
PMID: 39803154
Background Clinicians use prognostic biomarker/multi-gene-based tests for predicting recurrence in hormone receptor-positive/HER2-negative (HR+/HER2-) early-stage breast cancer (EBC). CanAssist Beast (CAB) uses the expression of five protein biomarkers in combination with...
2.
K M, Mangala S, Rathi E, Udupa K, Prasada K S, Shama P, et al.
Curr Med Chem
. 2024 Apr;
32(6):1121-1143.
PMID: 38584538
Ovarian cancer is one of the most familiar kinds of gynecological cancer seen in women. Though it is not as familiar as breast cancer, the survival rate for ovarian cancer...
3.
Dilli Batcha J, Gota V, Matcha S, Raju A, Rao M, Udupa K, et al.
Cancer Chemother Pharmacol
. 2024 Mar;
94(1):35-44.
PMID: 38441626
Background And Aim: Chronic myeloid leukemia is a myeloproliferative neoplasm associated with the specific chromosomal translocation known as the Philadelphia chromosome. Imatinib is a potent BCR-ABL tyrosine kinase inhibitor, which...
4.
Tholeti P, Uppangala S, Jayaram R, Udupa K, Kalthur G, Spears N, et al.
F1000Res
. 2023 Sep;
12:153.
PMID: 37767024
Background: Primary care physicians not only coordinate referrals to oncology services but can play a crucial role in successful fertility preservation referrals in cancer-diagnosed patients. Hence, it is important to...
5.
Dilli Batcha J, Raju A, Matcha S, S E, Udupa K, Gota V, et al.
Biology (Basel)
. 2023 Jan;
12(1).
PMID: 36671744
Background: Tamoxifen is useful in managing breast cancer and it is reported to have significant variability in its pharmacokinetics. This review aimed to summarize reported population pharmacokinetics studies of tamoxifen...
6.
Varghese S, Pai R, Prameela DSouza J, Badagabettu S, Udupa K, Pai A
J Vasc Nurs
. 2022 Nov;
40(4):167-171.
PMID: 36435599
No abstract available.
7.
Pinto R, Rao M, Roy A, Thomas L, Udupa K, Guddattu V
Curr Drug Saf
. 2022 Mar;
18(2):175-189.
PMID: 35331122
Background: Cancer patients are more vulnerable to developing drug-drug interactions as multiple medications are administered concomitantly with cytotoxic agents to treat the underlying comorbidities. These drug-drug interactions often receive less...
8.
Salama M, Ataman-Millhouse L, Sobral F, Terrado G, Scarella A, Bourlon M, et al.
JCO Glob Oncol
. 2022 Mar;
6():369-374.
PMID: 35275747
Purpose: Oncofertility practice continues to grow in developing countries despite the lack of health care services, especially those related to cancer care. The purpose of this study is to further...
9.
Kolesar J, Peh S, Thomas L, Baburaj G, Mukherjee N, Kantamneni R, et al.
Mol Cancer
. 2022 Feb;
21(1):61.
PMID: 35209919
The advent of molecular profiling has revolutionized the treatment of lung cancer by comprehensively delineating the genomic landscape of the epidermal growth factor receptor (EGFR) gene. Drug resistance caused by...
10.
Baburaj G, Damerla R, Udupa K, Parida P, Munisamy M, Kolesar J, et al.
Mol Biol Rep
. 2020 Oct;
47(10):8179-8187.
PMID: 33029702
Genomic profiling of tumors has become the mainstay for diagnosis, treatment monitoring and a guide to precision medicine. However, in clinical practice, the detection of driver mutations in tumors has...